Trendlines builds war chest; eyes combined markets of Israel, Singapore, China
The medical and agricultural technology firm is raising funds to better support its startups and help them penetrate the three markets.
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THE Trendlines Group is building its war chest. The Israel-based, Catalist-listed medical and agricultural technology (medtech, agritech) incubator is raising funds to better support its startups and help them penetrate the three markets it has set its sights on: Israel, Singapore and China.
Fresh from announcing a joint venture (JV) with Chinese private equity firm Shoushan Wealth Holdings last week, which will help finance its portfolio companies and support them in their expansion into China, Trendlines is also raising additional funds for medtech companies globally.
Todd Dollinger, co-chairman and chief executive officer (CEO) of the company, told The Business Times: "With our new China JV, the fund-raises that are in process are in US dollars and renminbi, and projected to reach a combined US$100 million in funds."
Copyright SPH Media. All rights reserved.
